Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
- PMID: 32622456
- PMCID: PMC7241320
- DOI: 10.1016/j.mayocp.2020.05.001
Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Comment in
-
In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.Mayo Clin Proc. 2020 Jul;95(7):1553-1556. doi: 10.1016/j.mayocp.2020.05.003. Epub 2020 May 21. Mayo Clin Proc. 2020. PMID: 32622458 Free PMC article. No abstract available.
Comment on
-
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.Mayo Clin Proc. 2020 Jun;95(6):1222-1230. doi: 10.1016/j.mayocp.2020.03.026. Epub 2020 Apr 4. Mayo Clin Proc. 2020. PMID: 32376099 Free PMC article. Review.
References
-
- Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019 (COVID-19) [published online ahead of print April 4, 2020]. Mayo Clin Proc. 10.1016/j.mayocp.2020.03.026. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources